14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
- PMID: 24824074
- DOI: 10.1016/j.autrev.2014.05.001
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Abstract
Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in the presence of at least one of the two major clinical manifestations (i.e. thrombosis or pregnancy morbidity) of the syndrome. However, several other autoantibodies shown to be directed to other proteins or their complex with phospholipids have been proposed to be relevant to APS but their clinical utility and their diagnostic value remains elusive. This report summarizes the findings, conclusions and recommendations of the "APS Task Force 3-Laboratory Diagnostics and Trends" meeting that took place during the 14th International Congress on Antiphospholipid Antibodies (APLA 2013, September 18-21, Rio de Janeiro, RJ, Brazil).
Keywords: Antiprothrombin antibodies; Domain I; IgA; Lupus anticoagulant; Risk; aCL.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.Lupus. 2011 Feb;20(2):191-205. doi: 10.1177/0961203310397082. Lupus. 2011. PMID: 21303836
-
'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.Lupus. 2011 Feb;20(2):182-90. doi: 10.1177/0961203310395055. Lupus. 2011. PMID: 21303835
-
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.Lupus. 2020 Oct;29(12):1601-1615. doi: 10.1177/0961203320954520. Epub 2020 Sep 3. Lupus. 2020. PMID: 32883160 Review.
-
16th International congress on antiphospholipid antibodies task force report on antiphospholipid syndrome laboratory diagnostics and trends.Lupus. 2023 Dec;32(14):1625-1636. doi: 10.1177/09612033231211820. Epub 2023 Nov 7. Lupus. 2023. PMID: 37933818 Free PMC article.
-
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.Lupus. 2020 Oct;29(12):1594-1600. doi: 10.1177/0961203320951260. Epub 2020 Aug 20. Lupus. 2020. PMID: 32819183 Review.
Cited by
-
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.Clin Rev Allergy Immunol. 2017 Aug;53(1):14-27. doi: 10.1007/s12016-016-8568-1. Clin Rev Allergy Immunol. 2017. PMID: 27342459 Review.
-
A Clinical Approach for Defining the Threshold between Low and Medium Anti-Cardiolipin Antibody Levels for QUANTA Flash Assays.Antibodies (Basel). 2016 May 25;5(2):14. doi: 10.3390/antib5020014. Antibodies (Basel). 2016. PMID: 31557995 Free PMC article.
-
Obstetric antiphospholipid syndrome.Lupus Sci Med. 2018 Sep 25;5(1):e000197. doi: 10.1136/lupus-2016-000197. eCollection 2018. Lupus Sci Med. 2018. PMID: 30364418 Free PMC article. Review.
-
New advances in genomics and epigenetics in antiphospholipid syndrome.Rheumatology (Oxford). 2024 Feb 6;63(SI):SI14-SI23. doi: 10.1093/rheumatology/kead575. Rheumatology (Oxford). 2024. PMID: 38320594 Free PMC article. Review.
-
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.Front Immunol. 2019 Aug 14;10:1948. doi: 10.3389/fimmu.2019.01948. eCollection 2019. Front Immunol. 2019. PMID: 31475009 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous